Try our Advanced Search for more refined results
October 23, 2017
SMITH v. ANTARES PHARMA, INC. et al
Case Number:
3:17-cv-08945
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 28, 2020
Antares Pharma Beats Suit Over 'Vague' Drug Statements
Antares Pharma Inc. again defeated a proposed securities class action alleging it misled investors about the risks of hypertension, suicide and depression associated with a testosterone medication after a New Jersey federal judge on Tuesday said the company's purported misrepresentations were "vague and general statements of optimism."
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login